TEARCARE MGX Trademark

Trademark Overview

On Wednesday, August 18, 2021, a trademark application was filed for TEARCARE MGX with the United States Patent and Trademark Office. The USPTO has given the TEARCARE MGX trademark a serial number of 90890290. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Tuesday, October 22, 2024. This trademark is owned by Sight Sciences, Inc.. The TEARCARE MGX trademark is filed in the Medical Instrument Products category with the following description:

Medical devices for the treatment of ophthalmological conditions

General Information

Serial Number90890290
Word MarkTEARCARE MGX
Filing DateWednesday, August 18, 2021
Status734 - FIFTH EXTENSION - GRANTED
Status DateTuesday, October 22, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 15, 2022

Trademark Statements

Pseudo MarkTEAR CARE MGX
Goods and ServicesMedical devices for the treatment of ophthalmological conditions

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateWednesday, October 6, 2021
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSight Sciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMenlo Park, CA 94025
Party NameSight Sciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMenlo Park, CA 94025

Trademark Events

Event DateEvent Description
Thursday, February 3, 2022ASSIGNED TO EXAMINER
Saturday, August 21, 2021NEW APPLICATION ENTERED
Wednesday, October 6, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, February 4, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 23, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 10, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 15, 2022PUBLISHED FOR OPPOSITION
Tuesday, March 15, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 27, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, September 27, 2022SOU EXTENSION 1 FILED
Tuesday, September 27, 2022SOU EXTENSION 1 GRANTED
Saturday, March 25, 2023SOU TEAS EXTENSION RECEIVED
Thursday, September 29, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, March 25, 2023SOU EXTENSION 2 GRANTED
Saturday, March 25, 2023SOU EXTENSION 2 FILED
Tuesday, October 10, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 28, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 6, 2023SOU TEAS EXTENSION RECEIVED
Friday, October 6, 2023SOU EXTENSION 3 FILED
Friday, October 6, 2023SOU EXTENSION 3 GRANTED
Monday, April 1, 2024SOU EXTENSION 4 FILED
Tuesday, December 19, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, December 19, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, December 19, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, April 1, 2024SOU EXTENSION 4 GRANTED
Tuesday, October 22, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, October 22, 2024SOU EXTENSION 5 FILED
Monday, April 1, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, April 2, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 22, 2024SOU EXTENSION 5 GRANTED
Monday, May 12, 2025TEAS STATEMENT OF USE RECEIVED
Tuesday, October 22, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

tearcare conditions ophthalmological treatment devices medical